Expertise in
2
conditions

Gary F. Lewis

Toronto, ON, CA 
Expertise in
2
conditions
Toronto, ON, CA 

Overview

Gary Lewis practices practicing medicine in Toronto, Canada.

Mr. Lewis is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Familial Hypertriglyceridemia, High Cholesterol, Type 2 Diabetes (T2D), and Atherosclerosis.

He is actively involved in clinical research, co-authoring 77 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Toronto, ON, Canada
Other Locations
Toronto, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Investigating the Plasma Lipoprotein Response to a Single Subcutaneous Dose of Analogue Glucagon-like Peptide-2 in Humans
Investigating the Plasma Lipoprotein Response to a Single Subcutaneous Dose of Analogue Glucagon-like Peptide-2 in Humans
Enrollment Status: Completed
Publish Date: June 14, 2022
Intervention Type: Drug
Study Drug: Teduglutide
Study Phase: Phase 2/Phase 3
Investigating the Release of Stored Enteral Lipids in Response to a Single Subcutaneous Dose of Analogue Glucagon-like Peptide-2 in Humans
Investigating the Release of Stored Enteral Lipids in Response to a Single Subcutaneous Dose of Analogue Glucagon-like Peptide-2 in Humans
Enrollment Status: Completed
Publish Date: May 25, 2022
Intervention Type: Drug
Study Drug: Teduglutide
Study Phase: Phase 2/Phase 3
Role of a Nitric Oxide Synthase Inhibitor on GLP-2 Mediated Intestinal Lipoprotein Release
Role of a Nitric Oxide Synthase Inhibitor on GLP-2 Mediated Intestinal Lipoprotein Release
Enrollment Status: Completed
Publish Date: March 27, 2020
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
View 2 Less Clinical Trials

77 Total Publications

Incretin-based therapies: Effects on plasma lipids and potential mechanisms.
Incretin-based therapies: Effects on plasma lipids and potential mechanisms.
Journal: Pharmacology & therapeutics
Published: April 14, 2026

Frequently Asked Questions about Gary F. Lewis

Is Gary F. Lewis a top-rated expert for Familial Hypertriglyceridemia?

MediFind is an objective health platform that identifies experts based on real-world data. Gary F. Lewis is classified as an Distinguished expert for Familial Hypertriglyceridemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Gary F. Lewis participate in research or clinical trials?

Yes. Gary F. Lewis has published 77 articles and abstracts on conditions like Familial Hypertriglyceridemia. You can view a list of Gary F. Lewis's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Lewis's expertise for a condition
ConditionClose
      View All 15 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile